New research reveals that B cells regulate obesity-associated inflammation and type 2 diabetes through two specific mechanisms. The research is from Boston University School of Medicine (BUSM). The study, published in the iProceedings of the National Academies of Sciences/i, indicates the importance of continuing to explore B cells as a therapeutic target to treat these diseases. Barbara Nikolajczyk, PhD, associate professor of microbiology at BUSM, is the study's senior ...
View the Original article
